Medico-social features of resistance development to new anti–TB drugs in patients with MDR/XDR TB Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Identification of TB specific IFN-γ-secreting T-cells in children with active TB and TB contacts Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
The clinical features and treatment of cases with MDR TB of adolescents Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007
Evaluation of TB antibodies using ELISA and M. tuberculosis DNA using PCR in children and adolescents from high-prevalence regions Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008
Mycobacterium tuberculosis resistance profiles in index and secondary TB cases from the same household Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 166s Year: 2003
The characteristics of TB processes in children exposed to household TB Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018
Prevention of TB in areas of low incidence Source: Eur Respir Mon 2012; 58: 72-83 Year: 2012
Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001
Tuberculosis in children exposed to MTB with different drug resistance patterns Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
The peculiarities of histological diagnostic of tuberculosis (TB) in HIV-infected patients in Ukraine Source: Eur Respir J 2006; 28: Suppl. 50, 20s Year: 2006
The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019
Clinical – immunological analyse revealing tuberculosis among the people with HIV infection in Armenia Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008